SGD S.A.:企業の戦略・SWOT・財務情報

◆英語タイトル:SGD S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6893
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:紙・包装
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

SGD S.A. – Strategy, SWOT and Corporate Finance Report
Summary

SGD S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

SGD S.A. (SGD), formerly known as Saint-Gobain Desjonquéres, is a glass packaging solutions provider in France. The company’s product portfolio includes an array of healthcare, beauty and pharmacy glass bottles. It offers injectable glass vials, infusion bottles, and oral and nasal vials. It also provides custom-made vials such as EasyLyo, and U Save. The company distributes various packaging products through its subsidiary, EMBELIA. The company’s products find application in industries such as cosmetics, and pharmacy. It operates through sales offices and production sites in France, Germany, India, and China. The company operates as a part of China Jianyin Investment Ltd. SGD is headquartered in Paris, France.

Scope

- Detailed information on SGD S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting SGD S.A. in the form of a SWOT analysis
- An in-depth view of the business model of SGD S.A. including a breakdown and examination of key business segments
- Intelligence on SGD S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about SGD S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of SGD S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess SGD S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on SGD S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
SGD S.A.: Company Overview 9
SGD S.A.: Overview and Key Facts 9
SGD S.A.: Overview 9
SGD S.A.: Key Facts 9
SGD S.A.: Key Employees 10
SGD S.A.: Major Products and Services 11
SGD S.A.: Company History 12
SGD S.A.: Locations and Subsidiaries 15
SGD S.A.: Key Competitors 17
SGD S.A.: Company Analysis 18
SGD S.A.: Business Description 18
SGD S.A.: SWOT Analysis 19
SGD S.A.: SWOT Overview 19
SGD S.A.: Strengths 19
SGD S.A.: Weaknesses 20
SGD S.A.: Opportunities 20
SGD S.A.: Threats 21
SGD S.A.: Corporate Financial Deals Activity 22
SGD S.A.: Financial Deals Overview 22
SGD S.A.: Top Deals 2014 – 2018YTD* 23
SGD S.A.: Private Equity and Ownership 24
SGD S.A.: Recent Developments 25
SGD S.A.: News and Events Summary 25
SGD S.A.: Business Expansion 26
SGD S.A.: Corporate Governance 27
SGD S.A.: Regulatory and Legal Events 27
SGD S.A.: Strategy and Operations 28
Appendix 29
Contact Us 29
Methodology 29
About MarketLine 30

List of Tables
Table 1: SGD S.A.: Key Facts
Table 2: SGD S.A.: Key Employees
Table 3: SGD S.A.: Company History
Table 4: SGD S.A.: Locations and Subsidiaries
Table 5: SGD S.A.: Key Competitors
Table 6: SGD S.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: SGD S.A.: Top Deals 2014 - 2018YTD*
Table 8: SGD S.A.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 9: SGD S.A.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 10: SGD S.A.: News and Events Summary
Table 11: SGD S.A.: Business Expansion
Table 12: SGD S.A.: Corporate Governance
Table 13: SGD S.A.: Regulatory and Legal Events
Table 14: SGD S.A.: Strategy and Operations

List of Figures
Figure 1: SGD S.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: SGD S.A.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 3: SGD S.A.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[SGD S.A.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arabian Bemco Contracting Co. Ltd.:企業の戦略・SWOT・財務分析
    Arabian Bemco Contracting Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arabian Bemco Contracting Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Alpine Immune Sciences Inc (NVLS):企業の財務・戦略的SWOT分析
    Summary Alpine Immune Sciences Inc (Alpine), formerly Nivalis Therapeutics Inc, is a pharmaceutical company that discovering and developing innovative, protein-based immunotherapies, immune synapse to treat cancer and autoimmune and inflammatory diseases. The has two products in the clinic for infla …
  • EFG International AG:企業の戦略・SWOT・財務情報
    EFG International AG - Strategy, SWOT and Corporate Finance Report Summary EFG International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Rubicon Research Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Rubicon Research Pvt Ltd (Rubicon), a subsidiary of Everstone Capital Management, is a drug delivery technology company that develops, manufactures and markets next-generation pharmaceutical products. The company’s products include central nervous system, cardiovascular, cough, cold and anti …
  • FibroStatin SL:製薬・医療:M&Aディール及び事業提携情報
    Summary FibroStatin SL (FibroStatin) is a drug development company that focuses on the development of treatment candidates for drug resistant lung cancer and idiopathic pulmonary fibrosis. The company’s pipeline products include T12/FST12 for NSCLC, GPBP-Mab/FSM26 for idiopathic pulmonary fibrosis a …
  • Equinor ASA.:企業の戦略・SWOT・財務情報
    Equinor ASA. - Strategy, SWOT and Corporate Finance Report Summary Equinor ASA. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • The Co-Operators Group Limited:企業の戦略的SWOT分析
    The Co-Operators Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Rhon-Klinikum AG (RHK):企業の財務・戦略的SWOT分析
    Summary Rhon-Klinikum AG (Rhon-Klinikum) is a healthcare service provider that offers medical care services. The center offers services such as nursing, physiotherapy, ergotherapy, logopaedics and dietician services. It provides medical assistance professions in the areas of functional diagnosis, la …
  • Nuevolution AB (NUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuevolution AB (Nuevolution) is a biopharmaceutical company focused on developing drug treatments for cancer and chronic inflammatory diseases. The company’s pipeline products include RORyt inhibitor, BRD (BD1), cytokine X, RORyt agonist, and GRP78. Its products are used for various indicati …
  • Outokumpu Oyj:企業のM&A・事業提携・投資動向
    Outokumpu Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Outokumpu Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Lonza Group Ltd (LONN):企業の財務・戦略的SWOT分析
    Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • ALS Therapy Development Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary ALS Therapy Development Institute (ALS TDI), formerly ALS Therapy Development Foundation, is a drug discovery center that offers research and healthcare services. The center's pipeline product include AT-1501, a novel antibody therapeutic that blocks specific immune cell activation and prote …
  • InterGen:企業の戦略的SWOT分析
    InterGen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Medline Industries, Inc.:企業のM&A・事業提携・投資動向
    Medline Industries, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medline Industries, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • T3D Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary T3D Therapeutics Inc (T3D) is a developer of solutions for the treatment of Alzheimer’s disease and Mild Cognitive Impairment. The company’s pipeline product include T3D-959, an optimal disease remedial therapeutic for the treatment of Alzheimer’s disease. It provides a potential to improve …
  • Fuji Electric Co Ltd (6504):企業の財務・戦略的SWOT分析
    Fuji Electric Co Ltd (6504) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Main Line Health System:企業の戦略的SWOT分析
    Main Line Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Stantec Inc (STN)-エネルギー分野:企業M&A・提携分析
    Summary Stantec Inc. (Stantec) is a consulting services company offering architectural, engineering, and environmental services. Its service portfolio includes architecture and interior design, building engineering, community design services, geomatics, geotechnical engineering, landscape architectu …
  • NCSG Crane & Heavy Haul Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary NCSG Crane & Heavy Haul Corp (NCSG), formerly NC Services Group Ltd is a construction equipment provider that offers mobile crane rental and heavy haul services. The company’s services comprise operated and maintained crane services, bare rental cranes, contract lifting, heavy hauling, on-si …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆